- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
CADx to distribute CAD system in 14 countries
CADx Medical Systems of Montreal has signed distribution agreements for its Second Look CAD mammography system that cover 14 countries. It will be available in the U.S. when it gains FDA approval. CADx will file for FDA premarket approval after
CADx Medical Systems of Montreal has signed distribution agreements for its Second Look CAD mammography system that cover 14 countries. It will be available in the U.S. when it gains FDA approval.
CADx will file for FDA premarket approval after clinical trials, which are under way at 11 U.S. sites, are complete. The newly signed distributorships are in Australia, New Zealand, Spain, Germany, Portugal, the U.K., Ireland, Belgium, Luxembourg, France, South Korea, Poland, Singapore, and Malaysia.
After a patients mammography film has been fed into a digitizer, Second Looks software analyzes it using proprietary algorithms. Second Look produces a printed paper image, highlighting areas of potential concern. Radiologists can use the printed image to assist with a diagnosis.
R2 Technology of Los Altos, CA, markets a similar CAD system known as the ImageChecker. GE Medical Systems plans to integrate ImageChecker into its Senographe 2000D as soon as it gains FDA clearance to read soft-copy images. Senographe has approval only for hard-copy reads.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
